10x Genomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026
10x Genomics (Nasdaq: TXG) will report fourth quarter and full year 2025 financial results after market close on Thursday, February 12, 2026.
Rhea-AI Summary
10x Genomics (Nasdaq: TXG) will report fourth quarter and full year 2025 financial results after market close on Thursday, February 12, 2026. A public conference call and live webcast for analysts and investors begins at 1:30 p.m. PT / 4:30 p.m. ET to discuss results, business developments and outlook. The earnings news release will be posted on the company's website prior to the call. Interested parties can access a live webcast of the fireside chat on the Investors section at https://investors.10xgenomics.com/. The webcast will be archived for replay for at least 45 days after the event.
Positive
- None.
Negative
- None.
Details
News Market Reaction – TXG
On Jan 23, the first trading day after this news, TXG closed 3.49% below the previous close.
Data tracked by StockTitan Argus for the Jan 23 session.
Key Figures
- Earnings release date
- February 12, 2026
- Q4 and full-year 2025 financial results release after market close
- Quarter end date
- December 31, 2025
- Fourth quarter and full-year 2025 period end
- Conference call time PT
- 1:30 p.m.
- Start time of earnings conference call Pacific Time
- Conference call time ET
- 4:30 p.m.
- Start time of earnings conference call Eastern Time
- Webcast replay period
- 45 days
- Archived webcast availability following the event
Historical Context
-
Completed 1-for-5 reverse stock split for Amcor ordinary shares.
-
Launched 1,000-patient autoimmune blood-based single-cell diagnostic study.
-
Multi-year Dana-Farber collaboration on tumor single cell and spatial profiling.
-
AI-driven immuno-oncology initiative using over 20,000 samples and 500M cells.
-
Planned presentation at 44th Annual J.P. Morgan Healthcare Conference.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Interested parties may access a live webcast of the fireside chat on the "Investors" section of the company's website at: https://investors.10xgenomics.com/. The webcast will be archived and available for replay for at least 45 days after the event.
About 10x Genomics
10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated research solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience and more, fueling powerful discoveries that are transforming the world's understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn, X, Facebook, Bluesky or YouTube.
Disclosure Information
10x Genomics uses filings with the Securities and Exchange Commission, its website (https://www.10xgenomics.com/), press releases, public conference calls, public webcasts and its social media accounts as means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.
Contacts
Investors: investors@10xgenomics.com
Media: media@10xgenomics.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/10x-genomics-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-12-2026-302667505.html
SOURCE 10x Genomics, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.